Astrazeneca plc
Exchange: NASDAQSector: HealthcareIndustry: Drug Manufacturers - General
AstraZeneca (LSE/STO/Nasdaq: AZN ) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca.
Did you know?
Pays a 1.73% dividend yield.
Current Price
$184.74
-1.40%GoodMoat Value
$228.37
23.6% undervaluedProfile
Valuation (TTM)
Market Cap$286.51B
P/E27.58
EV—
P/B5.89
Shares Out1.55B
P/Sales4.74
Revenue$60.44B
EV/EBITDA15.28
AZN (AZN) — Earnings Call Transcripts
No transcripts available yet
No earnings call transcripts are available for AZN yet. Check back after the next earnings report.
← Back to AZN overview